viable, but conditional strategies to inactivate SIRT1 spatially or temporally may be applicable.
Weismann recognized that his concept of the germ line could explain how nature trumped aging, at least at the species level. The findings of Liu et al. provide a molecular framework for how this crucial process can occur, and could eventually lead to new strategies to slow aging in the soma. A weight of evidence already indicates that SIRT1 protects somatic cells against aging by deacetylating factors regulating metabolic pathways, stress tolerance, and genomic stability (Finkel et al., 2009 ). This effect is enhanced when precious resources are shifted from germ line maintenance to somatic cell maintenance during food scarcity (Kirkwood, 1977) . Under these conditions, the premium may be on delaying reproduction until food becomes more available. The study by Liu et al. raises the fascinating possibility that SIRT1 is also called into action to promote germ cell quality control when resources are plentiful, that is, during times of food abundance. How does a cell in mitosis cope with a broken chromosome? According to findings presented by Royou et al. (2010) in this issue, neuroblasts in the fruit fly Drosophila have the capacity to reattach the broken pieces with thin tethers that contain DNA and some familiar mitotic proteins. Remarkably, in many cases, this emergency fix lasts long enough to allow the completion of cell division and can even rescue larval development.
In mitosis two sister kinetochores are built at the centromeres of each chromosome. The kinetochores attach to the mitotic spindle microtubules and move the chromosomes to align them at the metaphase plate. Then, at anaphase each chromosome separates into two chromatids that are ferried to opposite poles by kinetochores. Given the prominence of kinetochores in chromosome segregation, conventional wisdom suggests that chromosome fragments lacking centromeres would fail to segregate properly during mitosis. However, some studies report that the segregation of chromosome fragments lacking centromeres is remarkably resilient over several cell divisions (Malkova et al., 1996; Titen and Golic, 2008) .
To create acentric chromosome fragments under controlled conditions, Royou et al. expressed I-CreI endonuclease under the control of a heat shock promoter in third instar larvae. I-CreI induces a double-strand break at an endogenous 20 nucleotide sequence within the ribosomal DNA located on Drosophila sex chromosomes. As a consequence, I-CreI expression causes the Drosophila X chromosome to break into two pieces, a small fragment containing the centromere and a long acentric chromosome arm. Remarkably, the acentric fragments segregate successfully through multiple rounds of cell division, and their induction causes no detectable impairment in the development of third instar larvae into adult flies (though I-CreI expression does cause significant lethality when induced at earlier stages).
The authors examined larval neuroblasts expressing I-CreI by cytology and fluorescence video microscopy and find that they exhibit normal chromosomal alignment at metaphase. However, at anaphase there are a few lagging chroduct tape for Broken chromosomes A cell undergoing mitosis is presented with a potentially catastrophic situation when a DNA doublestrand break creates a chromosome fragment that lacks connection to a centromere. Royou et al. (2010) now reveal that this cellular crisis is averted in fruit fly neuroblasts by thin chromatin tethers that hold on to the ends of the broken chromosomes.
Cell 140, January 22, 2010 ©2010 Elsevier Inc. 179 matids that are shown to be acentric fragments of the X chromosome. After a few minutes most acentric fragments do eventually move and most are segregated appropriately to opposite poles, thus preserving the normal DNA content in the daughter cells (Figure 1 ). In the absence of centromeres and thus kinetochores, how are the acentric fragments able to move to the metaphase plate and eventually segregate appropriately, and what might account for their high frequency of successful segregation to opposite poles? Although we do not have the complete answers to these questions, the findings reported by Royou et al. reveal important and intriguing leads. The first clue comes from detailed cytological observations of the X chromosomes in cells with the I-CreI-induced double-strand breaks. In the majority of cells very thin chromatin strands, termed "tethers" by the authors, connect the acentric chromosome fragments to the centric fragments. Immunolabeling and expression of proteins tagged with green fluorescent protein (GFP) show that these tethers contain concentrations of several important mitotic proteins including Polo, Aurora-B, INCENP, and BubR1. Polo and Aurora-B are both kinases that participate in many aspects of mitosis and cytokinesis, and INCENP is a binding partner and activator of Aurora-B (Archambault and Glover, 2009; Ruchaud et al., 2007) . BubR1 is a large protein kinase with more specialized roles in chromosome movement and in the mitotic spindle checkpoint that inhibits anaphase onset until chromosomes are properly aligned at metaphase (Huang and Yen, 2009) . A unifying characteristic of these proteins is that they are normally concentrated in early mitosis at the centromere/kinetochore region. However, given that other mitotic centromere/kinetochore proteins such as Cid/CenpA or Mad2 are not detectably enriched on the tethers, the authors conclude that the observed phenomenon is not due to the induction of new centromeres, a mechanism that occurs in certain circumstances on acentric chromosome fragments. Do the proteins concentrated on the tethers have functional roles in the segregation of acentric fragments? Evidence from studies of mutant flies suggests that this is case for Polo and BubR1. Flies with certain hypomorphic mutations in genes encoding these proteins have little effect on survival to adulthood. However, when combined with I-CreI expression within third instar larvae, viability is greatly compromised. Close examination of these flies reveals that their acentric fragments are more likely to lack tethers and to exhibit a delay in anaphase segregation or completely fail to segregate. Moreover, when the acentric fragments do segregate, they more frequently fail to move to opposite poles resulting in a high percentage of daughter cells with abnormal chromosome content. Although the synthetic effects from the mutations might result from Polo and BubR1 activities that are independent of the tethers, the evidence for a more direct role is intriguing.
Many questions remain. Lacking kinetochores, how do acentric fragments congress to the metaphase plate? Possible mechanisms include the tethers themselves, or perhaps there are independent mechanisms of transport, such as ejection forces from the spindle pole or motor proteins associated with chromatin (chromokinesins). How do the tethers facilitate segregation in late anaphase? A mechanism proposed by the authors is that the acentric fragments move poleward at late anaphase because of the elasticity of the chromatin tethers resulting from stretching. Once they disentangle from each other, the acentric fragments could then be pulled to the poles.
If so, what holds the acentric fragments together during early anaphase when the normal chromatids and the centric fragments separate and move poleward? The authors hypothesize that components of the DNA repair machinery hold the acentric fragments together. However, DNA catenation is an equally likely possibility. Poleward tension imposed by the elasticity of the tethers in anaphase may be essential to favor decatenation of sister acentric fragments by the enzyme DNA topoisomerase II and thus might account for the delayed separation. The final and perhaps most important question is how do the tethers form? At this point, it is anyone's guess. The authors of the study speculate that the formation of tethers could involve unresolved replication intermediates or DNA repair machinery recruited to the break site.
DNA-containing, tether-like strands connecting chromosomes and chromosome fragments have been reported in a number of studies of mitosis and meiosis and may be far more widespread than previously appreciated (Chan et al., 2007; LaFountain et al., 2002) . In addi- (Center) Double-strand chromosome breaks in the Drosophila X chromosome would normally result in failure to segregate the fragments lacking connection to the centromeres. (Right) However, in many instances, the appearance of elastic chromatin tethers (red) allows acentric fragments to exhibit a delayed but successful segregation to opposite spindle poles (Royou et al., 2010). tion, recent studies have linked DNA damage and mitotic spindle checkpoints, previously regarded, at least outside yeast, as relatively distinct signaling pathways (Choi and Lee, 2008; Musaro et al., 2008) . The study by Royou et al. provides a peek into the repair kit for mitotic chromosomes. In it we find some familiar tools, adapted for unexpected applications. Delving further to characterize the complete toolkit will undoubtedly reveal additional surprises.
Comprehensive multidimensional analysis of cancer genomes has revealed a staggering level of complexity and variability even within tumors of the same histopathological subtype. These data highlight the breadth and depth of the constellation of genomic alterations in cancer. Although canonical signaling pathways seem to be universally deregulated in cancer (Cancer Genome Atlas Research Network, 2008) , different components of a pathway can be altered in different tumors. This variability affects tumor responses to targeted therapies and could explain the limited activity observed clinically when targeted therapies are deployed across a group of cancer patients with the same histopathological subtype of tumor. Hence, great effort is being devoted to designing and developing therapeutic regimens tailored to patients whose tumors carry particular molecular features. A marquee example is the drug trastuzumab, used for treating breast cancer. Patients with breast tumors harboring amplification or overexpression of the HER2/NEU gene, the target of trastuzumab, are more likely to show a clinical response than patients with tumors that do not (Smith et al., 2007) . But not all patients with such signature mutations show clinical benefit. One study reported that only six out of 100 breast cancer patients whose tumors carried HER2 amplification or overexpression derived survival benefits from trastuzumab treatment (Smith et al., 2007) . Therefore, understanding what dictates responsiveness to therapy in the clinic is one of the greatest challenges the oncology community faces, with significant medical and economic implications. Now Heidorn et al. (2010) , reporting in this issue, identify a new mechanism that underlies differential biochemical responsiveness to a targeted cancer therapy.
They show, in melanoma, that drugs that specifically inhibit the oncogene BRAF are effective in the subpopulation of melanomas (?45%) harboring BRAF mutations. However, of concern, they discovered that these drugs also unleash cancerpromoting effects in melanomas that harbor mutations in the RAS oncogene.
These findings may come as a surprise, as the signaling proteins RAS and RAF are depicted as components of the same pathway, and RAF is in fact considered to be an immediate downstream signaling surrogate for RAS in the linear ERK activation cascade. That said, groundwork hinting at the complex interplay between RAS and RAF has been laid by studies on the role of CRAF in melanoma. RAS proteins (NRAS, KRAS, and HRAS) directly activate RAF proteins (ARAF, BRAF, and CRAF) as part of the oncogenic RAS-RAF-MEK-ERK signal transduction cascade. The key
